Erdheim-Chester Disease: A Case Report of BRAF V600E–Negative, MAP2K1-Positive ECD Diagnosed by Blood Next-Generation Sequencing Assay and a Brief Literature Review
ONCOLOGY · 2023
DOI: 10.46883/2023.25921001 ↗Kurz gefasst
Fallbericht in der Zeitschrift ONCOLOGY, 2023. Verfasst von Ankita Aggarwal und 5 weiteren Autor:innen. Hauptthemen laut MEDLINE: Erdheim-Chester Disease. Die Arbeit wurde bisher 3-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Aggarwal, A., Taychert, M., Hasanin, L., Doll, D., Basuino, M. G., & Hasanein, H. (2023). Erdheim-Chester Disease: A Case Report of BRAF V600E–Negative, MAP2K1-Positive ECD Diagnosed by Blood Next-Generation Sequencing Assay and a Brief Literature Review. ONCOLOGY. https://doi.org/10.46883/2023.25921001
Vancouver
Aggarwal A, Taychert M, Hasanin L, Doll D, Basuino MG, Hasanein H. Erdheim-Chester Disease: A Case Report of BRAF V600E–Negative, MAP2K1-Positive ECD Diagnosed by Blood Next-Generation Sequencing Assay and a Brief Literature Review. ONCOLOGY. 2023. doi:10.46883/2023.25921001
BibTeX
@article{Aggarwal2023,
author = {Aggarwal, Ankita and Taychert, Mackenzie and Hasanin, Louay and Doll, Donald and Basuino, Mira Gabrielle and Hasanein, Hassan},
title = {Erdheim-Chester Disease: A Case Report of BRAF V600E–Negative, MAP2K1-Positive ECD Diagnosed by Blood Next-Generation Sequencing Assay and a Brief Literature Review},
journal = {ONCOLOGY},
year = {2023},
doi = {10.46883/2023.25921001}
}
EUVIMED